Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-05-03 Sale |
2022-05-04 7:01 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,504 | $4.7564 | $7,154 | 12,376 (Direct) |
View |
2021-12-21 Sale |
2021-12-23 6:58 pm |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
300 | $9.7345 | $2,920 | 34,555 (Direct) |
View |
2021-12-21 Sale |
2021-12-23 6:57 pm |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
250 | $9.7277 | $2,432 | 34,195 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-12-16 Option Award |
2022-12-20 5:20 pm |
N/A 2032-12-16 |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
115,740 | $0 | 132,442 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 5:19 pm |
N/A 2032-12-16 |
HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director |
115,740 | $0 | 129,192 (Direct) |
View |
2022-10-13 Exercise |
2022-10-17 4:38 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 67,758 (Direct) |
View |
2022-10-13 Tax Withholding |
2022-10-17 4:38 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $3.76 | 67,758 (Direct) |
View |
2022-10-13 Exercise |
2022-10-17 4:38 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 321,881 (Direct) |
View |
2022-10-13 Tax Withholding |
2022-10-17 4:38 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $3.76 | 321,881 (Direct) |
View |
2022-10-13 Exercise |
2022-10-17 4:37 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
5,814 | $0 | 86,108 (Direct) |
View |
2022-10-13 Tax Withholding |
2022-10-17 4:37 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
2,012 | $3.76 | 86,108 (Direct) |
View |
2022-10-13 Exercise |
2022-10-17 4:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,485 | $0 | 40,699 (Direct) |
View |
2022-10-13 Tax Withholding |
2022-10-17 4:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
861 | $3.76 | 40,699 (Direct) |
View |
2022-10-13 Exercise |
2022-10-17 4:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 65,540 (Direct) |
View |
2022-10-13 Tax Withholding |
2022-10-17 4:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $3.76 | 65,540 (Direct) |
View |
2022-07-25 Option Award |
2022-07-27 6:23 pm |
N/A 2032-07-25 |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
165,961 | $0 | 165,961 (Direct) |
View |
2022-07-25 Option Award |
2022-07-27 6:22 pm |
N/A 2032-07-25 |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
165,961 | $0 | 165,961 (Direct) |
View |
2022-07-25 Option Award |
2022-07-27 6:21 pm |
N/A 2032-07-25 |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
60,902 | $0 | 60,902 (Direct) |
View |
2022-07-25 Option Award |
2022-07-27 6:21 pm |
N/A 2032-07-25 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
165,961 | $0 | 165,961 (Direct) |
View |
2022-07-13 Exercise |
2022-07-15 4:58 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 71,275 (Direct) |
View |
2022-04-29 Other |
2022-07-15 4:58 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,505 | $3.842 | 71,275 (Direct) |
View |
2022-07-13 Tax Withholding |
2022-07-15 4:58 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $3.01 | 71,275 (Direct) |
View |
2022-07-13 Exercise |
2022-07-15 4:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 328,604 (Direct) |
View |
2022-04-29 Other |
2022-07-15 4:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,504 | $3.842 | 328,604 (Direct) |
View |
2022-07-13 Tax Withholding |
2022-07-15 4:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $3.01 | 328,604 (Direct) |
View |
2022-07-13 Exercise |
2022-07-15 4:56 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
5,814 | $0 | 88,120 (Direct) |
View |
2022-07-13 Tax Withholding |
2022-07-15 4:56 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
2,012 | $3.01 | 88,120 (Direct) |
View |
2022-07-13 Exercise |
2022-07-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,485 | $0 | 41,560 (Direct) |
View |
2022-07-13 Tax Withholding |
2022-07-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
860 | $3.01 | 41,560 (Direct) |
View |
2022-07-13 Exercise |
2022-07-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 67,552 (Direct) |
View |
2022-07-13 Tax Withholding |
2022-07-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $3.01 | 67,552 (Direct) |
View |
2022-04-29 Other |
2022-05-04 7:01 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,504 | $3.842 | 12,376 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 5:06 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 70,277 (Direct) |
View |
2022-04-13 Tax Withholding |
2022-04-15 5:06 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $6.07 | 70,277 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 330,815 (Direct) |
View |
2022-04-13 Tax Withholding |
2022-04-15 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $6.07 | 330,815 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 5:04 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
5,814 | $0 | 90,132 (Direct) |
View |
2022-04-13 Tax Withholding |
2022-04-15 5:04 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
2,012 | $6.07 | 90,132 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 5:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,484 | $0 | 42,420 (Direct) |
View |
2022-04-13 Tax Withholding |
2022-04-15 5:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
860 | $6.07 | 42,420 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 5:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 69,564 (Direct) |
View |
2022-04-13 Tax Withholding |
2022-04-15 5:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $6.07 | 69,564 (Direct) |
View |
2022-01-13 Exercise |
2022-01-14 5:09 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 72,289 (Direct) |
View |
2022-01-13 Tax Withholding |
2022-01-14 5:09 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $8.3 | 72,289 (Direct) |
View |
2022-01-13 Exercise |
2022-01-14 5:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 336,034 (Direct) |
View |
2022-01-13 Tax Withholding |
2022-01-14 5:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $8.3 | 336,034 (Direct) |
View |
2022-01-13 Exercise |
2022-01-14 5:07 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
5,814 | $0 | 92,144 (Direct) |
View |
2022-01-13 Tax Withholding |
2022-01-14 5:07 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
2,012 | $8.3 | 92,144 (Direct) |
View |
2022-01-13 Exercise |
2022-01-14 5:06 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,485 | $0 | 43,280 (Direct) |
View |
2022-01-13 Tax Withholding |
2022-01-14 5:06 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
966 | $8.3 | 43,280 (Direct) |
View |
2022-01-13 Exercise |
2022-01-14 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 71,576 (Direct) |
View |
2022-01-13 Tax Withholding |
2022-01-14 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $8.3 | 71,576 (Direct) |
View |
2021-10-29 Other |
2021-12-23 6:59 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
817 | $9.3585 | 24,653 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 6:58 pm |
N/A 2031-12-22 |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
31,355 | $0 | 34,555 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 6:58 pm |
N/A 2031-12-22 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
31,355 | $0 | 37,605 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 6:57 pm |
N/A 2031-12-22 |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
31,355 | $0 | 34,195 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 6:56 pm |
N/A 2031-12-22 |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
31,355 | $0 | 37,605 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 6:55 pm |
N/A 2031-12-22 |
HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director |
31,355 | $0 | 34,355 (Direct) |
View |
2021-10-13 Exercise |
2021-10-15 4:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,250 | $0 | 166,501 (Direct) |
View |
2021-10-13 Option Award |
2021-10-15 4:26 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
147,520 | $0 | 166,501 (Direct) |
View |
2021-10-13 Tax Withholding |
2021-10-15 4:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
433 | $10.55 | 166,501 (Direct) |
View |
2021-10-13 Exercise |
2021-10-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
3,646 | $0 | 732,087 (Direct) |
View |
2021-10-13 Option Award |
2021-10-15 4:25 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
586,251 | $0 | 732,087 (Direct) |
View |
2021-10-13 Tax Withholding |
2021-10-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
963 | $10.55 | 732,087 (Direct) |
View |
2021-10-13 Exercise |
2021-10-15 4:24 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
1,250 | $0 | 185,539 (Direct) |
View |
2021-10-13 Option Award |
2021-10-15 4:24 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
147,520 | $0 | 185,539 (Direct) |
View |
2021-10-13 Tax Withholding |
2021-10-15 4:24 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
433 | $10.55 | 185,539 (Direct) |
View |
2021-10-13 Exercise |
2021-10-15 4:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
552 | $0 | 57,259 (Direct) |
View |
2021-10-13 Option Award |
2021-10-15 4:23 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
36,437 | $0 | 57,259 (Direct) |
View |
2021-10-13 Tax Withholding |
2021-10-15 4:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
191 | $10.55 | 57,259 (Direct) |
View |
2021-10-13 Exercise |
2021-10-15 4:22 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 165,788 (Direct) |
View |
2021-10-13 Option Award |
2021-10-15 4:22 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
147,520 | $0 | 165,788 (Direct) |
View |
2021-10-13 Tax Withholding |
2021-10-15 4:22 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $10.55 | 165,788 (Direct) |
View |
Ownership |
2021-09-29 4:18 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
0 | $0 | 43,750 (Direct) |
View |
Ownership |
2021-09-29 4:16 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
0 | $0 | 43,750 (Direct) |
View |